Literature DB >> 15280359

Crystal structure and mutagenesis of a protein phosphatase-1:calcineurin hybrid elucidate the role of the beta12-beta13 loop in inhibitor binding.

Jason T Maynes1, Kathleen R Perreault, Maia M Cherney, Hue Anh Luu, Michael N G James, Charles F B Holmes.   

Abstract

Protein phosphatase-1 and protein phosphatase-2B (calcineurin) are eukaryotic serine/threonine phosphatases that share 40% sequence identity in their catalytic subunits. Despite the similarities in sequence, these phosphatases are widely divergent when it comes to inhibition by natural product toxins, such as microcystin-LR and okadaic acid. The most prominent region of non-conserved sequence between these phosphatases corresponds to the beta12-beta13 loop of protein phosphatase-1, and the L7 loop of toxin-resistant calcineurin. In the present study, mutagenesis of residues 273-277 of the beta12-beta13 loop of the protein phosphatase-1 catalytic subunit (PP-1c) to the corresponding residues in calcineurin (312-316), resulted in a chimeric mutant that showed a decrease in sensitivity to microcystin-LR, okadaic acid, and the endogenous PP-1c inhibitor protein inhibitor-2. A crystal structure of the chimeric mutant in complex with okadaic acid was determined to 2.0-A resolution. The beta12-beta13 loop region of the mutant superimposes closely with that of wild-type PP-1c bound to okadaic acid. Systematic mutation of each residue in the beta12-beta13 loop of PP-1c showed that a single amino acid change (C273L) was the most influential in mediating sensitivity of PP-1c to toxins. Taken together, these data indicate that it is an individual amino acid residue substitution and not a change in the overall beta12-beta13 loop conformation of protein phosphatase-1 that contributes to disrupting important interactions with inhibitors such as microcystin-LR and okadaic acid.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280359     DOI: 10.1074/jbc.M407184200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Structural basis for protein phosphatase 1 regulation and specificity.

Authors:  Wolfgang Peti; Angus C Nairn; Rebecca Page
Journal:  FEBS J       Date:  2012-02-24       Impact factor: 5.542

2.  Insight into the Molecular Mechanism for the Discrepant Inhibition of Microcystins (MCLR, LA, LF, LW, LY) on Protein Phosphatase 2A.

Authors:  Yixue Xu; Jiyuan Cui; Huiqun Yu; Wansong Zong
Journal:  Toxins (Basel)       Date:  2022-06-03       Impact factor: 5.075

3.  Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.

Authors:  Matthew S Kelker; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

4.  TIMAP inhibits endothelial myosin light chain phosphatase by competing with MYPT1 for the catalytic protein phosphatase 1 subunit PP1cβ.

Authors:  Xin Wang; Marya Obeidat; Laiji Li; Phuwadet Pasarj; Salah Aburahess; Charles F B Holmes; Barbara J Ballermann
Journal:  J Biol Chem       Date:  2019-07-17       Impact factor: 5.157

5.  Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology.

Authors:  Persoulla Nicolaou; Evangelia G Kranias
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

6.  Calcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl Isomerization.

Authors:  Alicia Guasch; Álvaro Aranguren-Ibáñez; Rosa Pérez-Luque; David Aparicio; Sergio Martínez-Høyer; M Carmen Mulero; Eva Serrano-Candelas; Mercè Pérez-Riba; Ignacio Fita
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.